Full-Time

Clinical Operations Manager

iota Biosciences

iota Biosciences

51-200 employees

Ultrasound-powered, implantable diagnostic and therapeutic devices

Compensation Overview

$145k - $200k/yr

+ Annual Bonus Plan + Long Term Incentive Plan + 401(k) match

Alameda, CA, USA

Hybrid

Hybrid role in Alameda.

Bachelor's, Master's

Category
Biology & Biotech (1)

Get referred to iota Biosciences

See people who can refer or advise you

Requirements
  • A Bachelor's degree in a scientific field, or an advanced degree with the required relevant experience alternative.
  • At least 8 years of relevant clinical research experience in the medical device field, or at least 5 years with an advanced degree.
  • At least 3 years of monitoring experience.
  • Direct experience with Class III medical device clinical studies.
  • Experience building and managing clinical operations teams.
  • Comprehensive knowledge of clinical operations, Good Clinical Practice, and applicable United States regulations.
  • Experience with global clinical studies, including Europe or Asia-Pacific regions.
  • Effective verbal and written communication skills.
  • Ability to manage multiple projects and priorities with strong organization and attention to detail.
  • Ability to interface effectively with translational medicine, regulatory, quality, and product development departments.
Responsibilities
  • Manage the clinical operations team by providing direction, subject matter expertise, training, and mentorship.
  • Design, develop, and evaluate clinical execution plans, including protocols, case report forms, consent forms, source documents, budgets, timelines, and gap analyses.
  • Own end-to-end clinical trial execution, including study start-up, site activation, site management, vendor oversight, study reports, and site and study close-out.
  • Provide technical direction to clinical research organizations and oversee vendor selection and management as needed to execute clinical studies.
  • Work with hospitals and investigators participating in clinical studies and maintain working relationships with key opinion leaders, investigating physicians, and site coordinators.
  • Provide input and support for post-clinical activities and product market launch.
  • Establish and support cross-functional teams to align Clinical, Regulatory, commercial, site operations, data monitoring and review, and safety surveillance and reporting expectations.
  • Ensure clinical research programs comply with company standard operating procedures, Good Clinical Practice, and applicable regulations.
Desired Qualifications
  • Clinical research certification such as Certified Clinical Research Professional or Certified Clinical Research Associate.
  • Experience with site and sponsor Food and Drug Administration Bioresearch Monitoring inspections.
  • Experience with urology clinical studies.
  • Superior problem-solving skills.
  • Effective interpersonal and communication skills.

iota Biosciences develops ultra-small, implantable bioelectronic devices that monitor and modulate bodily signals from inside the body. Their neural dust concept uses ultrasound to power these tiny implants and to carry data, enabling millimeter-scale devices implanted with minimal invasiveness. This approach eliminates bulky batteries and wired connections, allowing deep-tissue sensing and precise neuromodulation for real-time, closed-loop therapies. Astellas acquired Iota in 2020 to accelerate clinical development across areas like bladder disorders, autoimmune diseases, cancer, and neurological conditions.

Company Size

51-200

Company Stage

Acquired

Total Funding

$15M

Headquarters

Berkeley, California

Founded

2017

Get referred to iota Biosciences

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • iota posted a senior data scientist role in April 2026, signaling active R&D hiring.
  • iota.bio updated July 2026 still markets current openings, implying ongoing operations under Astellas.
  • Active patent families on ultrasonic sensing and power controls preserve technical optionality beyond bladder devices.

What critics are saying

  • The 2024 FDA IDE covers only three patients initially; failure kills the platform narrative.
  • iota still depends on one lead indication, so bladder-trial setbacks choke financing and prioritization.
  • Astellas can shelve iota after weak results, turning Berkeley IP into another abandoned bioelectronics asset.

What makes iota Biosciences unique

  • Ultrasound-powered implants eliminate batteries and wires, enabling millimeter-scale devices in inaccessible anatomy.
  • Astellas owns iota Biosciences, giving it capital, clinical infrastructure, and regulatory reach.
  • The bladder-wall implant program targets underactive bladder with direct stimulation, not symptom management.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Onsite Gym

Paid Vacation

Paid Parental Leave

Flexible Work Hours

401(k) Retirement Plan

Annual Bonus Plan

Long Term Incentive Plan (LTIP)

Stock Options

Family Planning Benefits

Fertility Treatment Support

Conference Attendance Budget

Professional Development Budget

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Growth & Insights

Headcount

6 month growth

-17%

1 year growth

-17%

2 year growth

-14%